Ab­Cellera ac­quires trans­mem­brane pro­tein pro­duc­er; Com­pass gains psy­che­del­ic IP port­fo­lio

Cana­di­an an­ti­body shop Ab­Cellera ac­quired Mass­a­chu­setts biotech Tetra­Ge­net­ics in an all-cash trans­ac­tion. While more spe­cif­ic de­tails were not made pub­licly avail­able …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER